These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 34864336)
1. Numerical simulation of iontophoresis for in-silico prediction of transdermal drugs in the dermal layers using skin impedance values. Bora DJ; Dasgupta R Comput Methods Programs Biomed; 2022 Feb; 214():106551. PubMed ID: 34864336 [TBL] [Abstract][Full Text] [Related]
2. Computational and experimental model of transdermal iontophorethic drug delivery system. Filipovic N; Saveljic I; Rac V; Graells BO; Bijelic G Int J Pharm; 2017 Nov; 533(2):383-388. PubMed ID: 28576549 [TBL] [Abstract][Full Text] [Related]
3. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier. Gratieri T; Kalia YN Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977 [TBL] [Abstract][Full Text] [Related]
4. The pretreatment effect of chemical skin penetration enhancers in transdermal drug delivery using iontophoresis. Choi EH; Lee SH; Ahn SK; Hwang SM Skin Pharmacol Appl Skin Physiol; 1999; 12(6):326-35. PubMed ID: 10545829 [TBL] [Abstract][Full Text] [Related]
5. Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress. Wang Y; Zeng L; Song W; Liu J Drug Deliv Transl Res; 2022 Jan; 12(1):15-26. PubMed ID: 33486687 [TBL] [Abstract][Full Text] [Related]
6. Ion-exchange membrane assisted transdermal iontophoretic delivery of salicylate and acyclovir. Xu Q; Ibrahim SA; Higuchi WI; Li SK Int J Pharm; 2009 Mar; 369(1-2):105-13. PubMed ID: 19041698 [TBL] [Abstract][Full Text] [Related]
7. Transdermal iontophoretic drug delivery: advances and challenges. Ita K J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291 [TBL] [Abstract][Full Text] [Related]
8. Enhanced Transdermal Drug Delivery by Sonophoresis and Simultaneous Application of Sonophoresis and Iontophoresis. Park J; Lee H; Lim GS; Kim N; Kim D; Kim YC AAPS PharmSciTech; 2019 Jan; 20(3):96. PubMed ID: 30694397 [TBL] [Abstract][Full Text] [Related]
9. Iontophoretic drug delivery system: a review. Semalty A; Semalty M; Singh R; Saraf SK; Saraf S Technol Health Care; 2007; 15(4):237-45. PubMed ID: 17673833 [TBL] [Abstract][Full Text] [Related]
11. An extended model based on the modified Nernst-Planck equation for describing transdermal iontophoresis of weak electrolytes. Imanidis G; Luetolf P J Pharm Sci; 2006 Jul; 95(7):1434-47. PubMed ID: 16724334 [TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Kanikkannan N; Kandimalla K; Lamba SS; Singh M Curr Med Chem; 2000 Jun; 7(6):593-608. PubMed ID: 10702628 [TBL] [Abstract][Full Text] [Related]
13. Transdermal iontophoresis: impact on skin integrity as evaluated by various methods. Kumar MG; Lin S Crit Rev Ther Drug Carrier Syst; 2008; 25(4):381-401. PubMed ID: 18540843 [TBL] [Abstract][Full Text] [Related]
14. Iontophoretic transdermal drug delivery: a multi-layered approach. Pontrelli G; Lauricella M; Ferreira JA; Pena G Math Med Biol; 2017 Dec; 34(4):559-576. PubMed ID: 27742748 [TBL] [Abstract][Full Text] [Related]
15. Iontophoresis for the cutaneous delivery of nanoentraped drugs. Andrade JFM; Cunha-Filho M; Gelfuso GM; Gratieri T Expert Opin Drug Deliv; 2023 Jun; 20(6):785-798. PubMed ID: 37119173 [TBL] [Abstract][Full Text] [Related]